Navigation Links
Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
Date:3/28/2008

Volcano s5i platform offers multiple diagnostic modalities on a single

system and user interface, providing choice for the first time to

physicians and administrators

SAN DIEGO, March 28 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today the U.S. and European launch of the s5-Revo and s5-FFR (fractional flow reserve) options for the s5i integrated Imaging platform. These two new product options now enable rotational IVUS and FFR to operate on the same integrated Volcano s5i Integrated Imaging System as Volcano's previous line of phased array IVUS catheters and functionality. For the first time, physicians can choose among three powerful diagnostic tools -- all on the same integrated IVUS platform.

Scott Huennekens, president and chief executive officer of Volcano, commented, "By adding high resolution rotational IVUS and pressure-based FFR to our already highly successful phased array s5 imaging platform, we will be providing a level of technology, clinical utility and convenience that is un-matched in the intravascular imaging field. No other company provides a system that integrates this level of functionality and convenience in a single platform. Our message now is simple: Volcano offers physicians all three technologies on one system -- you can choose which technology is best for your patient and clinical team."

Earlier generation consoles included only one of the three technologies now available on the s5i. If a hospit
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , VIENNA, Austria, November 19 /PR... vaccine program on one product candidate at an un... candidate AD02 is planned to enter into,Phase II ... company,immediately follows the completion of two... The company based its fast decision on the first ...
(Date:11/18/2009)..., Security personnel need to be able to find ex...tact with them. To aid such searches, the National...h support from the Department of Homeland Security..., Standard Reference Material (SRM) 2905, Trace Pa...boratory assay methods, the SRM will be helpful in...
(Date:11/18/2009)..., , RICHMOND, Calif., Nov. 18 /PRNewswire-F...GMO ) announced today that data from the Universit...afety study of Sangamo,s zinc finger nuclease (ZFN...ertently and prematurely disclosed on the internet... the University of Pennsylvania School of Medicine...
(Date:11/18/2009)..., , EAST GRINSTEAD, West Sussex, U.K. and CL...ystems, a Magellan Biosciences business and premie...y products for microbiology labs, has expanded its...and development facility to meet increasing global...susceptibility and identification testing. The exp...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
...MannKind Corporation (Nasdaq: MNKD ) today annou...(NDA) to the U.S. Food and Drug Administration (FD...er human [rDNA origin]) Inhalation Powder and the ... type 1 or type 2 diabetes mellitus for the contro...ople in the United States, or 8% of the population...
...tnership Will Increase Productivity to Meet Growin..., Indonesia (PRWEB) March 16, 2009 -- DuPont and...today announced an agreement that grants DuPont bu...cialize ICRR rice hybrids in Asia. , , , , ,Rice i...f of the world,s population. The growing populati...
...ialization and Authentication Technology & Ser...it Level to Secure Products and Protect Brands and...h, MA (PRWEB) March 16, 2009 -- PHARMORX Security&...ation, and track and trace technology services pro... comprehensive technology solutions. The company, ...
Other Biology Technology:MannKind Submits NDA for AFRESA for Treatment of Diabetes 2MannKind Submits NDA for AFRESA for Treatment of Diabetes 3DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 2DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 3PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace 2PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace 3
(Date:11/20/2009)...Brussel, November 19th 2009 - Bacteria possess an ...ming the building blocks of the cell. This is the ...Joris Messens of VIB, a life sciences research ins...e Universiteit Brussel. The scientists made this d...cterium Escherichia coli . By means of this model...
(Date:11/20/2009)...Surplus biomass from the production of flax shives...-flowered plant related to those which engulf fiel...his has been suggested by two studies carried out ...the journal Renewable and Sustainable Energy Revi...ental point of view, the production of bioethanol ...
(Date:11/20/2009)...Lehigh University,s Energy Research Center (ERC) h...f Energy (DOE) to develop methods of recovering an...carbon-dioxide (CO 2 ) compression process in a ca...ect is to facilitate carbon capture and sequestrat...f CO 2 , a greenhouse gas, emitted into the atmosp...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3New IOF report explains importance of FRAX in osteoporosis management 59716 1New IOF report explains importance of FRAX in osteoporosis management 59716 2Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 59711 1Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 59711 2New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 1New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 2New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 3New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 4
...clerosis (MS), neuroradiologists and neurologists ...urg have been able to visualize inflammatory tissu...up to now, with the aid of a new contrast medium, ... scientists have published their results in the on...n . , In particular at the early stage of the di...
...ers report this week that chronic exposure to estr...ome cognitive functions. Rats exposed to a steady ... working memory and response inhibition, the resea... the journal Behavioral Neuroscience . , The res...cts of estradiol on activities mediated by the pre...
...covers New Fraud Behavior Patterns, SAN DIEGO, Ju...d identity intelligence, today released the result...which provides an unprecedented,analysis of the cr...e of,identities stolen from the workplace by emplo...nderstanding of the harm resulting from an interna...
Other Biology News:Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2Chronic exposure to estrogen impairs some cognitive functions 2Chronic exposure to estrogen impairs some cognitive functions 3ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 2ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 3ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 4
UNOsphere S Support, 100 ml from Bio-Rad
S-Protein Agarose from Novagen
...a (Aph-1aL,S Loop 92-115), O2F1 Affinity Purified ...plex consisting of presenilin, nicastrin, Aph-1 an...proteolytic activity. The gamma secretase complex ...e proteins including Amyloid precursor protein, No...
... Epitope: A BALB/c mouse was immunized with Gluta...ecommended Storage: Store vial at -20 C prior to ...below for extended storage. Avoid cycles of freez...tely clear after standing at room temperature. ...
Biology Products: